RADIOPHARM THERANOSTICS LTD获得数据安全监测委员会积极建议,加速推进177Lu-RAD202一期"Heat"剂量递增临床试验

美股速递
Oct 01, 2025

RADIOPHARM THERANOSTICS LTD近日宣布,该公司收到了数据安全监测委员会(DSMC)的积极建议,决定加速推进177Lu-RAD202一期"Heat"剂量递增临床试验。

这一积极的建议表明,该临床试验的安全性和有效性数据令监管机构满意,为公司进一步推进这一创新疗法的开发提供了有力支持。177Lu-RAD202作为公司核心在研产品,此次获得加速推进的建议将有助于更快地验证其治疗潜力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10